Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.

Mueller M, Yuan J, McCann UD, Hatzidimitriou G, Ricaurte GA.

Int J Neuropsychopharmacol. 2013 May;16(4):791-801. doi: 10.1017/S1461145712000582. Epub 2012 Jul 24.

PMID:
22824226
2.

Dopamine is not essential for the development of methamphetamine-induced neurotoxicity.

Yuan J, Darvas M, Sotak B, Hatzidimitriou G, McCann UD, Palmiter RD, Ricaurte GA.

J Neurochem. 2010 Aug;114(4):1135-42. doi: 10.1111/j.1471-4159.2010.06839.x. Epub 2010 Jun 1.

3.

Heating induces aggregation and decreases detection of serotonin transporter protein on western blots.

McLane MW, Hatzidimitriou G, Yuan J, McCann U, Ricaurte G.

Synapse. 2007 Oct;61(10):875-6.

PMID:
17623834
4.

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

Xie T, Tong L, McLane MW, Hatzidimitriou G, Yuan J, McCann U, Ricaurte G.

Neuropsychopharmacology. 2006 Dec;31(12):2639-51. Epub 2006 Jan 25. Erratum in: Neuropsychopharmacology. 2008 Feb;33(3):712-3.

5.

Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys.

Yuan J, Hatzidimitriou G, Suthar P, Mueller M, McCann U, Ricaurte G.

J Pharmacol Exp Ther. 2006 Mar;316(3):1210-8. Epub 2005 Nov 17.

PMID:
16293712
6.

Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates.

Ricaurte GA, Mechan AO, Yuan J, Hatzidimitriou G, Xie T, Mayne AH, McCann UD.

J Pharmacol Exp Ther. 2005 Oct;315(1):91-8. Epub 2005 Jul 13.

PMID:
16014752
7.

Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons.

Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, Ricaurte GA.

Neuropsychopharmacology. 2006 Feb;31(2):339-50.

8.

Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.

Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G.

Neuropsychopharmacology. 2004 Jul;29(7):1270-81.

9.

Retraction.

Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD.

Science. 2003 Sep 12;301(5639):1479. No abstract available.

PMID:
12970544
10.

Response to O'Shea and Colado: the MDMA neurotoxicity profile might provide clues to mechanisms.

Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD.

Trends Pharmacol Sci. 2003 Jun;24(6):275. No abstract available.

PMID:
12823952
11.

Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge.

Taffe MA, Davis SA, Yuan J, Schroeder R, Hatzidimitriou G, Parsons LH, Ricaurte GA, Gold LH.

Neuropsychopharmacology. 2002 Dec;27(6):993-1005.

12.
13.

Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity.

Reneman L, Booij J, Habraken JB, De Bruin K, Hatzidimitriou G, Den Heeten GJ, Ricaurte GA.

Synapse. 2002 Dec 1;46(3):199-205.

PMID:
12325046
14.
15.

Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity.

Xie T, Tong L, Barrett T, Yuan J, Hatzidimitriou G, McCann UD, Becker KG, Donovan DM, Ricaurte GA.

J Neurosci. 2002 Jan 1;22(1):274-83.

16.

Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin.

Christopoulou M, Derartinian H, Hatzidimitriou G, Iatrou L.

J Craniomaxillofac Surg. 2001 Apr;29(2):118-25.

PMID:
11465435
17.

Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin.

Christopoulou M, Derartinian H, Hatzidimitriou G, Iatrou I.

J Maxillofac Surg. 2001 Apr;29(2):118-125.

PMID:
11308290
18.

Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity.

Kim S, Westphalen R, Callahan B, Hatzidimitriou G, Yuan J, Ricaurte GA.

J Pharmacol Exp Ther. 2000 May;293(2):625-33.

PMID:
10773037
19.
21.

N-methylation dissociates methamphetamine's neurotoxic and behavioral pharmacologic effects.

Fasciano J, Hatzidimitriou G, Yuan J, Katz JL, Ricaurte GA.

Brain Res. 1997 Oct 10;771(1):115-20.

PMID:
9383014
22.
23.

Effects of 2-deoxy-D-glucose on methamphetamine-induced dopamine and serotonin neurotoxicity.

Callahan B, Yuan J, Stover G, Hatzidimitriou G, Ricaurte G.

J Neurochem. 1998 Jan;70(1):190-7.

24.

Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drug.

McCann UD, Yuan J, Hatzidimitriou G, Ricaurte GA.

J Pharmacol Exp Ther. 1997 Jun;281(3):1487-98.

PMID:
9190887
25.

Fenfluramine-induced loss of serotonin transporters in baboon brain visualized with PET.

Scheffel U, Szabo Z, Mathews WB, Finley PA, Yuan J, Callahan B, Hatzidimitriou G, Dannals RF, Ravert HT, Ricaurte GA.

Synapse. 1996 Dec;24(4):395-8.

PMID:
10638827
26.

Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse.

Sparago M, Wlos J, Yuan J, Hatzidimitriou G, Tolliver J, Dal Cason TA, Katz J, Ricaurte G.

J Pharmacol Exp Ther. 1996 Nov;279(2):1043-52.

PMID:
8930215
27.

Prolactin response to fenfluramine is independent of serotonin release.

McCann UD, Hatzidimitriou G, Ricaurte GA.

Eur J Pharmacol. 1996 Sep 26;312(2):R1-2.

PMID:
8894606
29.

Highly potent indanamine serotonin uptake blockers as radiotracers for imaging serotonin uptake sites.

Suehiro M, Scheffel UA, Ravert HT, Ricaurte GA, Hatzidimitriou G, Dannals RF, Bøgesø KP, Wagner HN Jr.

Nucl Med Biol. 1994 Nov;21(8):1083-91.

PMID:
9234366
30.

Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated.

McCann U, Hatzidimitriou G, Ridenour A, Fischer C, Yuan J, Katz J, Ricaurte G.

J Pharmacol Exp Ther. 1994 May;269(2):792-8.

PMID:
7514223
31.

3,4-Methylenedioxymethamphetamine, serotonin and memory.

Ricaurte GA, Markowska AL, Wenk GL, Hatzidimitriou G, Wlos J, Olton DS.

J Pharmacol Exp Ther. 1993 Aug;266(2):1097-105. Erratum in: J Pharmacol Exp Ther 1994 Jan;268(1):529.

PMID:
8102642
32.

Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.

Scanzello CR, Hatzidimitriou G, Martello AL, Katz JL, Ricaurte GA.

J Pharmacol Exp Ther. 1993 Mar;264(3):1484-91.

PMID:
7680719
33.

Postembedding immunocytochemical localization of paramyxovirus antigens by light and electron microscopy.

Schwendemann G, Wolinsky JS, Hatzidimitriou G, Merz DC, Waxham MN.

J Histochem Cytochem. 1982 Dec;30(12):1313-9.

PMID:
6296222

Supplemental Content

Loading ...
Support Center